Casgevy and Lyfgenia: Two gene therapies approved for sickle cell disease

Yale doctors discuss the implications of these treatments recently approved by the FDA for those with the debilitating blood disorder.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news